Navigation Links
Vermillion Reports First Quarter 2012 Results
Date:5/15/2012

the company resolve these corporate issues satisfactorily as we continue to pursue our operational goals around the commercialization of OVA1 and the development of our pipeline.

"As we advance through 2012, we will remain focused on improving coverage and reimbursement, as they are key drivers for adoption. We continue to seek opportunistic partnerships for our product pipeline, with the goal of accelerating development and bringing additional resources to the commercial effort. We expect all of our efforts to result in an increase in the number of OVA1 tests performed, and for this to range between 4,100 and 4,400 in the second quarter of 2012."

Conference Call and Webcast
Vermillion will hold a conference call to discuss its first quarter financial results later today, Tuesday, May 15, 2012 at 4:30 p.m. Eastern time. Management will host the presentation, followed by a question and answer period.

Date: Tuesday, May 15, 2012
Time: 4:30 p.m. Eastern time (1:30 p.m. Pacific time)
Dial-In Number: 1-800-268-5851
International: 1-303-223-2680
Conference ID#: 21589040

The conference call will be broadcast simultaneously here and available for replay via the investor section of the company's Web site at www.vermillion.com.

Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact Liolios Group at 1-949-574-3860.

A replay of the call will be available approximately two hours after the call and until May 29, 2012.

Toll-free replay number: 1-800-633-8284
International replay number: 1-402-977-9140
Replay pin number: 21589040

About OVA1
OVA1 is a blood test for pre-surgical assessment of ovarian tumors f
'/>"/>

SOURCE Vermillion, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Vermillion Reports Fourth Quarter and Full Year 2011 Results
2. Vermillion Sharpens Focus and Streamlines Operations in 2012
3. Vermillion Receives Notice of Allowance for 5th Biomarker Patent Related to Peripheral Artery Disease
4. Vermillion Reports Results for the Second Quarter 2011
5. Vermillion Announces Notice of Allowance for Peripheral Artery Disease (PAD) Patent
6. Vermillion Announces Joining Russell Microcap® Index
7. Vermillion Announces Notice of Allowance for Alzheimer Patent
8. Vermillion Announces the Appointment of Bruce Huebner to its Board of Directors
9. Vermillion to Host Conference Call to Present Company Update and Review Financial Results for the First Quarter 2011
10. Stephens Initiates Coverage on Vermillion
11. Vermillion Announces Notice of Allowance of Patent for Breast Cancer Biomarkers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... 2013 On 25-28 July, 2013, UPCP ... Paris - the beautiful city of lights. , According ... is revolutionizing the medical world. Understanding and integrating genetic ... hallmark of this transformation. Much of the present medical ... epidemiologic studies of large cohorts that do not take ...
(Date:5/20/2013)... In Early 2013, Dr. Ritchie ... related illnesses , announced his vision for creating a ... his protocol for treating Chronic Inflammatory Response Syndrome (CIRS). ... to achieve certification in the Shoemaker Protocol. , ... the Shoemaker Protocol in other parts of the country, ...
(Date:5/19/2013)... 2013 Switzerland’s MS Tûranor PlanetSolar ... new speed record for a transatlantic crossing by a ... on April 25, 2013, the solar powered boat sailed ... average speed of 5.3 knots before reaching Marigot, St. ... 2013. The first-of-its-kind catamaran completed this year’s passage across ...
(Date:5/17/2013)... 17, 2013 Topricin Pain Relief ... has been listed among nationally recommended over-the-counter (OTC) ... conducted by "U.S. News" Health in collaboration with ... “No. 1 Pharmacists Recommended designation” in the ... OTC brands, and is the only homeopathic formula ...
Breaking Biology Technology:The International Congress on Personalized Medicine - Up Close and Personalized 2013 in Paris 2Dr. Ritchie Shoemaker Certifies Third Physician in His Treatment Protocol for Chronic Inflammatory Response Syndrome (CIRS) 2MS Tûranor PlanetSolar Sets World Speed Record for Transatlantic Crossing by Solar Electric Vessel 2MS Tûranor PlanetSolar Sets World Speed Record for Transatlantic Crossing by Solar Electric Vessel 3MS Tûranor PlanetSolar Sets World Speed Record for Transatlantic Crossing by Solar Electric Vessel 4MS Tûranor PlanetSolar Sets World Speed Record for Transatlantic Crossing by Solar Electric Vessel 5MS Tûranor PlanetSolar Sets World Speed Record for Transatlantic Crossing by Solar Electric Vessel 6Pharmacists' Picks: Topical BioMedics' Topricin Listed on Top Recommended OTC Health Products 2
... Fiserv Inc. has unveiled a program of healthcare ... processing and health-plan administration. , ,Spurred on ... banking is a set of services which includes ... payments between parties in healthcare transactions. , ...
... The increased use of clinical technologies in healthcare does ... for care decisions, particularly when technology vendors include strong ... developers market their products more directly to consumers, they ... attendees of the recent Digital Healthcare Conference ...
... events, is coming to Milwaukee again on June 22 and 23 ... both global and Wisconsin-area technology companies. , ,The conference will feature ... Networks , Agilent , EqualLogic , Inacom , ... Runner Business Class and other companies. , ,Attendees will have ...
Cached Biology Technology:Liability issues not seen as roadblock to healthcare technology advancements 2Liability issues not seen as roadblock to healthcare technology advancements 3
(Date:5/17/2013)... Researchers at Rutgers, The State University of New Jersey, ... proprietary new formulation called Visikol TM that effectively ... be used in place of chloral hydrate, which is ... but which is tightly regulated by the Drug Enforcement ... , Clearing solutions, or clearing agents, are vital for ...
(Date:5/17/2013)... May 17, 2013, Shenzhen, China---- Why Tibetan antelope ... Qinghai-Tibetan Plateau? In a collaborative research published in ... BGI, and other institutes provide evidence that some ... adaption to harsh highland environments. The data in ... specific genetic mechanisms and the biology of other ...
(Date:5/17/2013)... for Experimental Biology (FASEB) released a new analysis ... highlighting the devastating impact of sequestration on the nation,s ... a May 15th Senate Appropriations Committee hearing featuring NIH ... $1.6 billion cut the agency sustained in FY 2013 ... the scientific community." , According to data from ...
Breaking Biology News(10 mins):New formula invented for microscope viewing, substitutes for federally controlled drug 2New formula invented for microscope viewing, substitutes for federally controlled drug 3The genome sequence of Tibetan antelope sheds new light on high-altitude adaptation 2
... research at the University of Haifa, Israel, has made a ... of white blood cells that play a role in the ... discovered can assist in the development of drugs that are ... human body, unlike most of the existing drugs that attempt ...
... key gene mutation responsible for type 2 diabetes in nearly ... study, which originated in Italy and was validated at UCSF, ... major drop in the body,s ability to make insulin receptors ... to absorb sugar. This drop in insulin receptors leads to ...
... This press release is available in German . ... of time, show changes in their mechanical properties. The exact ... However, the microscopic structure and the complexity of the systems ... team led by Professor Andreas Bausch from the Chair of ...
Cached Biology News:How much can a cell uptake? 2How much can a cell uptake? 3Type 2 diabetes linked to single gene mutation in 1 in 10 patients 2
activating transcription factor 4 (tax-responsive enhancer element B67),...
Reactivity: Human...
... fosmid (40kb), and large plasmid insert (10-20kb) ... BAC vector. On command 20-50 fold copy ... DNA purification. Available with blue-white screening (pEZ ... the highest insert stability. Kits include electrocompetent ...
... Error-free cloning of BAC (100+kb), fosmid (40kb), ... insert stability than any othe BAC vector. ... high yields and easy recombinant DNA purification. ... transcription-free (pSMART VC) vectors for the highest ...
Biology Products: